BACKGROUND: The current study tested the hypothesis that the clinical outcome of patients with localized esophageal carcinoma after preoperative chemoradiotherapy (CTRT) depends on histology. METHODS: The authors stratified patients by adenocarcinoma (ACA) or squamous cell carcinoma (SCC) and compared the overall survival (OS) and patterns of failure among patients achieving pathologic complete response (pathCR) and <pathCR after preoperative CTRT. A correlation between baseline clinical stage and posttherapy pathologic response was made for ACA and SCC. RESULTS: Of the 235 patients who underwent preoperative CTRT, 42 (18%) had SCC and 193 (82%) had ACA. In the ACA group, 56 patients (29%) achieved a pathCR and in the SCC group 13 patients (31%) achieved a pathCR. In the ACA group, a larger proportion of pathCR patients (n=44; 79%) than <pathCR patients (n=82; 60%) were alive at the time of last follow-up (P=0.01) and pathCR patients had a longer OS than <pathCR patients (P=0.0006). However, in the SCC group OS or proportion alive did not differ significantly between pathCR and <pathCR patients (P>or=0.05). In the ACA group, a greater portion of <pathCR patients (32%) than pathCR patients (16%) had distant metastases (P=0.02) and the distant metastases-free survival of pathCR patients was longer than that of <pathCR patients (P=0.0012). In the SCC group, the proportion or time to distant-metastases did not differ significantly. Pretreatment clinical stage did not correlate with pathologic response for either histology. CONCLUSIONS: The results of the current study suggest that the clinical biology of SCC and ACA is different after CTRT. An investigation of molecular and patient genetics is needed to improve therapy. Copyright (c) 2005 American Cancer Society.
BACKGROUND: The current study tested the hypothesis that the clinical outcome of patients with localized esophageal carcinoma after preoperative chemoradiotherapy (CTRT) depends on histology. METHODS: The authors stratified patients by adenocarcinoma (ACA) or squamous cell carcinoma (SCC) and compared the overall survival (OS) and patterns of failure among patients achieving pathologic complete response (pathCR) and <pathCR after preoperative CTRT. A correlation between baseline clinical stage and posttherapy pathologic response was made for ACA and SCC. RESULTS: Of the 235 patients who underwent preoperative CTRT, 42 (18%) had SCC and 193 (82%) had ACA. In the ACA group, 56 patients (29%) achieved a pathCR and in the SCC group 13 patients (31%) achieved a pathCR. In the ACA group, a larger proportion of pathCR patients (n=44; 79%) than <pathCR patients (n=82; 60%) were alive at the time of last follow-up (P=0.01) and pathCR patients had a longer OS than <pathCR patients (P=0.0006). However, in the SCC group OS or proportion alive did not differ significantly between pathCR and <pathCR patients (P>or=0.05). In the ACA group, a greater portion of <pathCR patients (32%) than pathCR patients (16%) had distant metastases (P=0.02) and the distant metastases-free survival of pathCR patients was longer than that of <pathCR patients (P=0.0012). In the SCC group, the proportion or time to distant-metastases did not differ significantly. Pretreatment clinical stage did not correlate with pathologic response for either histology. CONCLUSIONS: The results of the current study suggest that the clinical biology of SCC and ACA is different after CTRT. An investigation of molecular and patient genetics is needed to improve therapy. Copyright (c) 2005 American Cancer Society.
Authors: Guillaume S Chevrollier; Danica N Giugliano; Francesco Palazzo; Scott W Keith; Ernest L Rosato; Nathaniel R Evans Iii; Adam C Berger Journal: J Gastrointest Surg Date: 2019-02-26 Impact factor: 3.452
Authors: Daniel Solomon; Muhammad Abbas; Yael Feferman; Riad Haddad; Gali Perl; Yulia Kundel; Sara Morgenstern; Nikolai Menasherov; Hanoch Kashtan Journal: Ann Surg Oncol Date: 2021-03-11 Impact factor: 5.344
Authors: Chantal M den Bakker; Justin K Smit; Anna M E Bruynzeel; Nicole C T van Grieken; Freek Daams; Sarah Derks; Miguel A Cuesta; John T M Plukker; Donald L van der Peet Journal: J Thorac Dis Date: 2017-07 Impact factor: 2.895
Authors: David W Cescon; Penelope A Bradbury; Kofi Asomaning; Jessica Hopkins; Rihong Zhai; Wei Zhou; Zhaoxi Wang; Matthew Kulke; Li Su; Clement Ma; Wei Xu; Ariela L Marshall; Rebecca Suk Heist; John C Wain; Thomas J Lynch; David C Christiani; Geoffrey Liu Journal: Clin Cancer Res Date: 2009-04-21 Impact factor: 12.531
Authors: James M Donahue; Francis C Nichols; Zhuo Li; David A Schomas; Mark S Allen; Stephen D Cassivi; Aminah Jatoi; Robert C Miller; Dennis A Wigle; K Robert Shen; Claude Deschamps Journal: Ann Thorac Surg Date: 2009-02 Impact factor: 4.330